QUOIN PHARMACEUTICALS LT-ADR (QNRX)
US74907L3006 - ADR
QUOIN PHARMACEUTICALS LT-ADR
NASDAQ:QNRX (12/19/2024, 6:24:30 PM)
After market: 0.5904 -0.06 (-8.72%)0.6468
+0.08 (+14.99%)
Company Profile
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.
Company Info
QUOIN PHARMACEUTICALS LT-ADR
23 Hata'as Street
Kfar Saba
P: 97299741444
CEO: Shai Yarkoni
Employees: 4
Website: https://quoinpharma.com/
QNRX News
10 hours ago - ChartmillDiscover the top movers in Thursday's pre-market session and stay informed about market dynamics.Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
11 hours ago - Quoin Pharmaceuticals, Inc.Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical StudyGroundbreaking ‘Whole Body’ Study will be conducted by Dr. Amy Paller at Northwestern University Up to eight subjects will have QRX003 applied twice daily...
a day ago - Quoin Pharmaceuticals, Inc.Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical StudiesClinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of TestingSignificant Improvement in Skin...
8 days ago - ChartmillThese stocks are moving in today's after hours sessionTop movers in Wednesday's after hours session
16 days ago - ChartmillThe trading volume of these stocks is deviating from the norm in today's session.Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
a month ago - Quoin Pharmaceuticals, Inc.Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial ResultsQuoin Initiates Peeling Skin Syndrome Clinical Program Further Expansion of International Reach for Netherton Syndrome Clinical Trials Significant...
QNRX Twits
Here you can normally see the latest stock twits on QNRX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
